Gottlieb Worries Vaccine Policy Could Spark Federalism Debate
Vaccination policies could result in arguments over states' rights instead of public health concerns, outgoing US FDA commissioner warns.
You may also be interested in...
Measles Hearings Offer Counterpoint To Pricing Spotlight: Vaccines Touted As Cost-Effective Solution To Outbreaks
Congressional hearings on the recent outbreaks of measles and other vaccine-preventable diseases offered a positive theme for the industry during the ongoing drug pricing debate.
New US FDA draft guidance says that the agency will no longer change the proper names of originator biologics to include a four-letter suffix, although the agency will continue to attach suffixes to future approvals.
INFOGRAPHIC: Wait time for confirmed commissioner has been trending down.